Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer

Clinical trial NCT06218810 · RECRUITING

Trial details

NCT number: NCT06218810
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer Microsatellite Stable Colorectal Carcinoma RAS Mutation Cadonilimab

Start date: 2024-01-01
Primary completion: 2025-12-31
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.